Avoiding the pain of the not-so-mystical placebo effect with the almost-magical run-in period
Nothing kills biotech companies like an active placebo.  More often than not the press release ...

Targeting tumour metabolism: the next land grab?
The sale of Avila to Celgene may mark the pinnacle of the market for kinase inhibitors in ...